Source link : https://newshealth.biz/health-news/fda-oks-first-gene-therapy-implant-for-a-rare-eye-disease/
March 7, 2025 — The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only implantable therapy that uses cell technology to deliver a protein that helps slow the disease’s progression. MacTel is a slowly progressing eye disease […]
The post FDA OKs First Gene Therapy Implant for a Rare Eye Disease first appeared on News Health.
Author : News Health
Publish date : 2025-03-10 04:40:00
Copyright for syndicated content belongs to the linked Source.